Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 30,231Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 30GLAXOSMITHKLINE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 11117871

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-3535

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-03-13

blank

02

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 11117871

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-3535

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-03-13

blank

03

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 11117871

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-3535

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-03-13

blank

04

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 11117871

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-3535

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-03-13

blank

05

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 11117871

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-3535

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-03-13

blank

06

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 8815884

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-1238

Delist Requested :

Patent Use Description : TREATMENT OF ANEMIA DU...

Patent Expiration Date : 2027-06-22

blank

07

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 8815884

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-1238

Delist Requested :

Patent Use Description : TREATMENT OF ANEMIA DU...

Patent Expiration Date : 2027-06-22

blank

08

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 8815884

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-1238

Delist Requested :

Patent Use Description : TREATMENT OF ANEMIA DU...

Patent Expiration Date : 2027-06-22

blank

09

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 8815884

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-1238

Delist Requested :

Patent Use Description : TREATMENT OF ANEMIA DU...

Patent Expiration Date : 2027-06-22

blank

10

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 8815884

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-1238

Delist Requested :

Patent Use Description : TREATMENT OF ANEMIA DU...

Patent Expiration Date : 2027-06-22

blank